The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Mokrysheva N.G.

Éndokrinologicheskiĭ nauchnyĭ tsentr, Moskva

Mamedova E.O.

FGBU "ndokrinologicheskiĭ nauchnyĭ tsentr" Minzdrava RF, Moskva

Pigarova E.A.

FGU Éndokrinologicheskiĭ nauchnyĭ tsentr Minzdravsotsrazvitiia RF, Moskva

Berezkina Yu.A.

Endocrinology Research Center, Ministry of Health of Russia, Moscow, Russia

Vorontsov A.V.

FGU Éndokrinologicheskiĭ nauchnyĭ tsentr Minzdravsotsrazvitiia RF

Azizyan V.N.

Endocrinology Research Centre, Moscow, Russia

Grigor'ev A.Iu.

FGU Éndokrinologicheskiĭ nauchnyĭ tsentr, Moskva

Alekseeva T.R.

N.N. Blokhin Russian Cancer Research Center, Moscow, Russia

Kutin M.A.

NII neĭrokhirurgii im. N.N. Burdenko RAMN, Moskva

Kochatkov A.V.

Institut khirurgii im. A.V. Vishnevskogo, Moskva

Rozhinskaia L.Ia.

FGU Éndokrinologicheskiĭ nauchnyĭ tsentr, Moskva

Multiple endocrine neoplasia type 1 syndrome with three classical components and chiasm glioma: Specific features of target organ lesions and a clinical observation

Authors:

Mokrysheva N.G., Mamedova E.O., Pigarova E.A., Berezkina Yu.A., Vorontsov A.V., Azizyan V.N., Grigor'ev A.Iu., Alekseeva T.R., Kutin M.A., Kochatkov A.V., Rozhinskaia L.Ia.

More about the authors

Journal: Therapeutic Archive. 2015;87(12): 122‑127

Read: 2493 times


To cite this article:

Mokrysheva NG, Mamedova EO, Pigarova EA, et al. . Multiple endocrine neoplasia type 1 syndrome with three classical components and chiasm glioma: Specific features of target organ lesions and a clinical observation. Therapeutic Archive. 2015;87(12):122‑127. (In Russ.)
https://doi.org/10.17116/terarkh20158712122-127

Recommended articles:
Economic issues of medi­cal care for hype­rparathyroidism. Part 1. Primary hype­rparathyroidism. Medi­cal Technologies. Asse­ssment and Choice. 2025;(1):51-61
Myco­tic pseudoaneurysm of inte­rnal caro­tid artery in chro­nic fungal infe­ction. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(9):151-156

References:

  1. Rostomyan L.G., Rozhinskaya L.Ya., Tyul'pakov A.N., Mokrysheva N.G. Osobennosti diagnostiki i lecheniya patsientov s sindromom mnozhestvennykh endokrinnykh neoplazii 1-go tipa. Consilium Medicum. 2010;12:87-93.
  2. Thakker RV, Newey PJ, Walls GV, Bilezikian J, Dralle H, Ebeling PR, Melmed S, Sakurai A, Tonelli F, Maria Luisa Brandi. Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). Journal of Clinical Endocrinology and Metabolism. 2012;97(9):2990-3011. doi:10.1210/jc.2012-1230.
  3. Thakker RV. Multiple endocrine neoplasia type 1 (MEN1). Best Practice and Research Clinical Endocrinology and Metabolism. 2010;24(3):355-370. doi:10.1016/j.beem.2010.07.003.
  4. Rostomyan L.G., Rozhinskaya L.Ya., Tyul'pakov A.N. Adenoma gipofiza i sindrom mnozhestvennykh endokrinnykh neoplazii 1-go tipa. V kn: Klinicheskaya endokrinologiya. Pod red. akad. RAN i RAMN I.I. Dedova. M.; 2011.
  5. Agarwal SK, Ozawa A, Mateo CM, Marx SJ. The MEN1 gene and pituitary tumours. Hormone Research. 2009;71(suppl 2): 131-138. doi:10.1159/000192450.
  6. Verges B, Boureille F, Goudet P, Murat A, Beckers A, Sassolas G, Cougard P, Chambe B, Montvernay C, Calender A. Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter study. Journal of Clinical Endocrinology and Metabolism. 2002;87:457-465. doi:10.1210/jc.87.2.457.
  7. Mamedova E.O., Przhiyalkovskaya E.G., Pigarova E.A., Mokrysheva N.G., Dzeranova L.K., Tyul'pakov A.N. Adenomy gipofiza v ramkakh nasledstvennykh sindromov. Problemy endokrinologii. 2014;60(4):51-59. doi:10.14341/probl201460451-59.
  8. Pinskii S.B., Beloborodov V.A. Sindrom mnozhestvennykh endokrinnykh neoplazii 1-go tipa. Sibirskii meditsinskii zhurnal. 2012;1:124-127.
  9. Reid MD, Balci S, Saka B, Adsay NV. Neuroendocrine tumors if the pancreas: current concepts and controversies. Endocrine pathology. 2014;25(1):65-79. doi:10.1007/s12022-013-9295-2.
  10. Tonelli F, Giudici F, Giusti F, Brandi M-L. Gastroenteropancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1. Cancers. 2012;4:504-522. doi:10.3390/cancers4020504.
  11. Pieterman CRC, Conemans EB, Dreijerink KMA. de Laat JM, Timmers HTM, Vriens MR, Valk GD. Thoracic and duodenopancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1 — natural history and function of menin in tumorigenesis. Endocrine Related Cancer. 2014;21(3):R121-R142. doi:10.1530/erc-13-0482.
  12. Hanazaki K, Sakurai A, Munekage M Ichikawa K, Namikawa T, Okabayashi T, Imamura M. Surgery for a gastroenteropancreatic neuroendocrine tumor (GEPNET) in multiple endocrine neoplasia type 1. Surgery Today. 2013;43:229-236. doi:10.1007/s00595-012-0376-5.
  13. Sakurai A, Yamazaki M, Suzuki S, Fukushima T, Imai T, Kikumori T, Okamoto T, Horiuchi K, Uchino S, Kosugi S, Yamada M, Komoto I, Hanazaki K, Itoh M, Kondo T, Mihara M, Imamura M. Clinical features of insulinoma in patients with multiple endocrine neoplasia type 1: analysis of the database of the MEN Consortium of Japan. Endocrine Journal. 2012;59:859-866. doi:10.1507/endocrj.ej12-0173.
  14. Giudici F, Nesi G, Brandi ML, Tonelli F. Surgical management of insulinomas in multiple endocrine neoplasia type 1. Pancreas. 2012;41:547-553. doi:10.1097/mpa.0b013e3182374e08.
  15. Crippa S, Zerbi A, Boninsegna L, Capitanio V, Partelli S, Balzano G, Pederzoli P, Di Carlo V, Falconi M. Surgical management of insulinomas: short- and long-term outcomes after enucleations and pancreatic resections. Archives of Surgery. 2012;147(3): 261-266. doi:10.1001/archsurg.2011.1843.
  16. Thomas-Marques L, Murat A, Delemer B, Penfornis A, Cardot-Bauters C, Baudin E, Niccoli-Sire P, Levoir D, Choplin Hdu B, Chabre O, Jovenin N, Cadiot G, Groupe des Tumeurs Endocrines (GTE). Prospective endoscopic ultrasonographic evaluation of the frequency of nonfunctioning pancreaticoduodenal endocrine tumors in multiple endocrine neoplasia type 1. The American Journal of Gastroenterology. 2006;101:266-273. doi:10.1111/j.1572-0241.2006.00367.x.
  17. Åkerström G, Stålberg P, Hellman P. Surgical management of pancreatico-duodenal tumors in multiple endocrine neoplasia syndrome type 1. Clinics. 2012;67(S1):173-178. doi:10.6061/clinics/2012(sup01)29.
  18. Tonelli F. How to follow up and when to operate asymptomatic pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1? Journal of Clinical Gastroenterology. 2014;48(5): 387-389. doi:10.1097/mcg.0000000000000087.
  19. Pigarova E.A., Dzeranova L.K. Sandostatin i Sandostatin LAR pri metabolicheskikh, neiroendokrinnykh i onkologicheskikh zabolevaniyakh. Ozhirenie i metabolizm. 2011;1:26-30.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.